Cyclo Therapeutics, Inc.
CYTH
Revenue
234.23k
▲66.95k▲40.02%
3 Months ChangeAssets
4.72M
▼-2.45M▼-34.14%
3 Months ChangeLiabilities
9.84M
▲3.29M▲50.15%
3 Months ChangeFree Cash Flow
-4.37M
▲464.61k▲9.61%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-09
Form 8-K
ID: 0001437749-24-030919
2024-10-08
Form 8-K
ID: 0001437749-24-030897
2024-09-09
Form 8-K
ID: 0001437749-24-028746
2024-08-22
Form 8-K
ID: 0001437749-24-027572
2024-08-14
Form 10-Q
ID: 0001437749-24-026889
2024-07-17
Form 8-K
ID: 0001437749-24-022904
2024-06-11
Form 8-K
ID: 0001437749-24-019923
2024-05-15
Form 10-Q
ID: 0001437749-24-017038
2024-01-22
Form 8-K
ID: 0001437749-24-001779
2023-12-28
Form 8-K
ID: 0001437749-23-035495